Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical Trial Ongoing for SEP-786, Oral Small...
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR...
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.68 | 11.6471099522 | 23.01 | 26.21 | 23 | 134692 | 24.79521468 | CS |
4 | 1.2 | 4.89995916701 | 24.49 | 26.34 | 20.68 | 153610 | 23.88784672 | CS |
12 | 2.19 | 9.31914893617 | 23.5 | 26.34 | 18.62 | 240393 | 22.5829019 | CS |
26 | 2.19 | 9.31914893617 | 23.5 | 26.34 | 18.62 | 240393 | 22.5829019 | CS |
52 | 2.19 | 9.31914893617 | 23.5 | 26.34 | 18.62 | 240393 | 22.5829019 | CS |
156 | 2.19 | 9.31914893617 | 23.5 | 26.34 | 18.62 | 240393 | 22.5829019 | CS |
260 | 2.19 | 9.31914893617 | 23.5 | 26.34 | 18.62 | 240393 | 22.5829019 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales